Related Experiment Video
Updated: Jul 16, 2025
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment
1Department of Hematology and Breast Cancer, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, China.
Abstract:
Melanoma, the most aggressive form of cutaneous malignancy arising from melanocytes, is frequently characterized by metastasis. Despite considerable progress in melanoma therapies, patients with advanced-stage disease often have a poor prognosis due to the limited efficacy, off-target effects, and toxicity associated with conventional drugs. Nanotechnology has emerged as a promising approach to address these challenges with nanoparticles capable of delivering therapeutic agents specifically to the tumor microenvironment (TME). However, the clinical approval of nanomedicines for melanoma treatment remains limited, necessitating further research to develop nanoparticles with improved biocompatibility and precise targeting capabilities. This comprehensive review provides an overview of the current research on nano-drug delivery systems for melanoma treatment, focusing on liposomes, polymeric nanoparticles, and inorganic nanoparticles. It discusses the potential of these nanoparticles for targeted drug delivery, as well as their ability to enhance the efficacy of conventional drugs while minimizing toxicity. Furthermore, this review emphasizes the significance of interdisciplinary collaboration between researchers from various fields to advance the development of nanomedicines. Overall, this review serves as a valuable resource for researchers and clinicians interested in the potential of nano-drug delivery systems for melanoma treatment and offers insights into future directions for research in this field.
Insights
Nanoparticles offer a promising solution for melanoma treatment by delivering drugs directly to the tumor microenvironment (TME). Further research is needed to improve nanoparticle biocompatibility and targeting for advanced melanoma therapies.
Area of Science:
- Oncology
- Nanomedicine
- Materials Science
Background:
- Melanoma, a severe skin cancer, often metastasizes, leading to poor prognoses in advanced stages.
- Conventional melanoma treatments face limitations due to efficacy, toxicity, and off-target effects.
Purpose of the Study:
- To review current nano-drug delivery systems for melanoma treatment.
- To highlight the potential of nanoparticles in enhancing melanoma therapy efficacy and reducing toxicity.
Main Methods:
- Comprehensive review of existing research on nano-drug delivery systems for melanoma.
- Focus on liposomes, polymeric nanoparticles, and inorganic nanoparticles.
- Analysis of targeted drug delivery capabilities and toxicity profiles.
Main Results:
- Nanoparticles show potential for targeted delivery to the tumor microenvironment (TME).
- Nano-drug delivery systems can enhance conventional drug efficacy while minimizing side effects.
- Liposomes, polymeric nanoparticles, and inorganic nanoparticles are key areas of research.
Conclusions:
- Nanotechnology offers a promising avenue for improving melanoma treatment outcomes.
- Further development of biocompatible and precisely targeted nanoparticles is crucial.
- Interdisciplinary collaboration is essential for advancing nanomedicine in melanoma therapy.
